[Regeneration Biotech] Announcement of the Board's Election of Chairman
Key facts
- [Regeneration Biotech] Announcement of the Board's Election of Chairman
- Regeneration Biotech announced that the Board of Directors has re-elected Tsai Yi-Wen as Chairman following a general election of directors due to expiration of term.
- Source: PR Times
- Date: May 20, 2026
Direct answer
Regeneration Biotech announced that the Board of Directors has re-elected Tsai Yi-Wen as Chairman following a general election of directors due to expiration of term.
- Citation
- [Regeneration Biotech] Announcement of the Board's Election of Chairman (May 20, 2026), PR Times
- Source
- PR Times
- Date
- May 20, 2026
Regeneration Biotech announced that the Board of Directors has re-elected Tsai Yi-Wen as Chairman following a general election of directors due to expiration of term.
📋 Article Processing Timeline
- 📰 Published: May 20, 2026 at 09:00
- 🔍 Collected: May 21, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 21, 2026 at 08:36 (36 min after Collected)
1. Date of the resolution of the Board of Directors or date of change: 115/05/20
2. Personnel category (Chairman or General Manager): Chairman
3. Name of the former incumbent: Tsai Yi-Wen
4. Resume of the former incumbent: Tsai Yi-Wen / Chairman of the Company
5. Name of the new incumbent: Tsai Yi-Wen
6. Resume of the new incumbent: Tsai Yi-Wen / Chairman of the Company
7. Situation of the change (e.g., resignation, dismissal, term expiration, job adjustment, layoff, retirement, death, or new appointment): Expiration of term.
8. Reason for the change: General re-election of directors.
9. Effective date of the new appointment: 115/05/20
10. Other matters to be specified (if the entity of the event or resolution belongs to a publicly issued or higher company, this material information also meets the matters specified in Article 7, Paragraph 6 of the Enforcement Rules of the Securities and Exchange Act that have a significant impact on shareholders' equity or securities prices): None.
2. Personnel category (Chairman or General Manager): Chairman
3. Name of the former incumbent: Tsai Yi-Wen
4. Resume of the former incumbent: Tsai Yi-Wen / Chairman of the Company
5. Name of the new incumbent: Tsai Yi-Wen
6. Resume of the new incumbent: Tsai Yi-Wen / Chairman of the Company
7. Situation of the change (e.g., resignation, dismissal, term expiration, job adjustment, layoff, retirement, death, or new appointment): Expiration of term.
8. Reason for the change: General re-election of directors.
9. Effective date of the new appointment: 115/05/20
10. Other matters to be specified (if the entity of the event or resolution belongs to a publicly issued or higher company, this material information also meets the matters specified in Article 7, Paragraph 6 of the Enforcement Rules of the Securities and Exchange Act that have a significant impact on shareholders' equity or securities prices): None.
FAQ
What is the current management status of Regeneration Biotech?
Following a general election of directors, Ms. Tsai Yi-Wen will continue to serve as Chairman.
When was this announcement made?
The Board of Directors reached the resolution on May 20, 115.
What is the reason for the change?
The change is due to the expiration of the term of office and the subsequent general re-election of the Board.